Delayed quote
Deal at a glance
Priced at $83, ticker ANT
Anthropic, PBC priced its Class A IPO on Nov 18, 2026. Shares were expected to begin trading on the Nasdaq Global Select Market on Nov 19 under the symbol ANT.
980 million shares at $83.00. Upsized from 825 million and from a $70-$78 range. Company release, Nov 18; proceeds = 980M × $83.
956,351,354 shares by Anthropic; 23,648,646 by selling stockholders. The company does not receive the selling-stockholder proceeds. Company release.
About $1.08 trillion on a shares-outstanding basis and about $1.5 trillion fully diluted, as reported by Axios, Nov 18. See the calculator for the share-count basis.
A concurrent private placement of non-voting shares at the IPO price, from a group that press reports said included Nvidia, Google, Microsoft, AMD, Broadcom, Micron, and TSMC Partners. This is not IPO proceeds. CNBC, Nov 18.
Scenario calculator
What a share price would imply
Move the price to see implied company value on two share-count bases, versus the $83 IPO price and the May 2026 Series H valuation. These are mechanical illustrations, not forecasts or a recommendation.
13.24 billion shares, estimated
18.17 billion shares, estimated
Percentage change from $83.00
Versus the $965B post-money valuation on May 28, 2026
Share counts are estimates, not a final cap table. They start from the share table in the Nov 10, 2026 amended S-1, as summarized in public explainers: about 13.087 billion shares outstanding after the then-planned 825 million-share offering and concurrent placement, and about 18.013 billion on that filing's "additional adjustments" total (a fully diluted stand-in, built at the $74 midpoint). This calculator adds the 155 million-share upsizing announced on Nov 18, giving about 13.242 billion outstanding and 18.168 billion fully diluted. Treasury-method option dilution moves with the share price, and the final prospectus may differ. Axios's reported $1.08 trillion / $1.5 trillion figures at $83 are close to the pre-upsizing math. October run-rate revenue of about $81 billion is an operating metric defined in the company's materials, not GAAP revenue and not a forecast. The greenshoe is a 30-day option on up to 147 million additional shares (about $12.20 billion at $83) and had not been reported as exercised as of this build.
From the prospectus
Financial snapshot
Figures below come from press reports of Anthropic's IPO prospectus and from the company's IPO fact sheet. They are historical or operating metrics, not guidance.
| Item | Figure | Source |
|---|---|---|
| Revenue, nine months ended Sep 30, 2026 | $33.24B | CNBC, Nov 18, citing the prospectus. About 1,200% above the same period a year earlier. |
| Revenue, third quarter of 2026 | $17.0B | Company IPO fact sheet. |
| Revenue, first half of 2026 | $16.3B | Amended S-1, as summarized in contemporaneous filing explainers. |
| Revenue, full year 2025 / 2024 | $4.6B / $0.39B | Same filing coverage of the S-1. |
| Run-rate revenue, Oct 31, 2026 | ~$81B | Company fact sheet and CNBC. An operating metric (trailing 28-day usage fees × 13, plus monthly subscriptions × 12), not a substitute for reported revenue. CNBC said it was up about $10B from the prior month. |
| Operating loss, first nine months of 2026 | $1.3B | Amended S-1, as summarized in filing explainers. |
| Net loss, first nine months of 2026 | $104B | CNBC, Nov 19. It said about $94.3B of that came from changes in the fair value of convertible notes, derivatives, and SAFEs. The year-earlier period's net loss was $25.1B. |
Also reported
Structure and context
| Item | What is known |
|---|---|
| Listing | Nasdaq Global Select, symbol ANT. Offering expected to close Nov 20, 2026, subject to customary conditions. Underwriters include Goldman Sachs and Morgan Stanley. Company release, Nov 18. |
| Corporate form | Delaware public benefit corporation. The S-1 describes a Long-Term Benefit Trust and special share classes, including Class F founder voting stock and Class T trust stock. See the prospectus for the actual governance terms. |
| Greenshoe | 30-day option for underwriters to buy up to 147 million additional Class A shares. Company release. Not counted as raised unless it is exercised. |
| Demand Reported | Press reports said the book was about six times oversubscribed. That is a demand claim, not an official proceeding size. Al Jazeera, Nov 19. |
| Retail allocation Reported | Coverage before pricing said Anthropic wanted a larger-than-usual retail slice, around 20% of the deal versus a more typical 5% to 10%. Treat this as reported intent, not a confirmed final allocation. MarketWatch / Morningstar. |
| Strategic holders Reported | TechCrunch, citing people familiar, said Amazon owned nearly 15% and Google almost 14% around the IPO. TechCrunch, Nov 18. |
| Co-founder sales Reported | CNBC, citing the prospectus, said each of the seven co-founders was selling 3.38 million shares, about $1.96 billion in total at $83. CNBC, Nov 18. |
| Employee wealth Scenario | CNBC reported that, at a $1.5 trillion valuation, about 4,250 of roughly 5,300 employees could be millionaires, with about 1,200 above $10 million, excluding the seven co-founders. This is a scenario, not a confirmed payout. CNBC, Nov 19. |
2026 path
Road to the listing
Confidential IPO filing
Anthropic said it had confidentially filed for a U.S. IPO. Reuters, Jun 1.
S-1 made public
The registration statement was publicly filed. Press reports put the date at Oct 26. Al Jazeera, Nov 19.
Range set at $70 to $78
An amended filing set an expected range of $70 to $78, with 825 million shares then planned. CNBC, Nov 18.
Priced at $83, upsized to 980 million shares
6.4% above the top of the range. Registration declared effective the same day. Company release.
First day of trading, 9:30 a.m. ET
Shares were expected to begin trading on Nasdaq under ANT. Company release.
Offering expected to close
Subject to customary closing conditions. This is the expected settlement date, not a prediction about the second trading session. Company release.
Private rounds
Funding timeline
Official company announcements are marked as such. Where Anthropic did not publish a valuation, that field is left blank or labeled as reported.
| Date | Round | Raised | Post-money |
|---|---|---|---|
| May 28, 2021 | Series A Official | $124M | Not disclosed |
| Apr 29, 2022 | Series B Official | $580M | Not disclosed |
| May 23, 2023 | Series C Official | $450M | Reported about $4.1B-$4.5B; not in the company post |
| Jan 2024 | Series D Reported | $750M | About $18.4B, per later databases and Forbes, Jan 11, 2024. No matching Anthropic press release was found. |
| Mar 3, 2025 | Series E Official | $3.5B | $61.5B |
| Sep 2, 2025 | Series F Official | $13B | $183B |
| Feb 12, 2026 | Series G Official | $30B | $380B |
| May 28, 2026 | Series H Official | $65B | $965B |
| Nov 18, 2026 | IPO pricing Official | $81.34B | About $1.08T / $1.5T, as reported; see calculator |
Scale check
Largest IPOs by initial proceeds
Initial deal size only, not including any underwriter overallotment (greenshoe), from Renaissance Capital's all-time global IPO list. Amounts are nominal and unadjusted for inflation.
SpaceX's initial IPO was $75.0 billion on Jun 11, 2026. After underwriters fully exercised the greenshoe, total proceeds were about $85.7 billion, per CNBC, Jun 15, 2026. Anthropic's own greenshoe (up to 147 million shares, about $12.20 billion at $83) is still only an option. A separate $26 billion concurrent private placement sits alongside Anthropic's IPO and is not included in the $81.34 billion bar above.
Sourced coverage
Headlines with dates
These are real articles, not a simulated ticker feed. Timestamps are publication dates, not invented intraday clocks.
Anthropic prices the initial public offering at $83.00
980 million Class A shares, trading expected Nov 19 on Nasdaq as ANT, close expected Nov 20, greenshoe of up to 147 million shares.
IPO raises over $81 billion, the largest offering on record
Prices above the $70-$78 range, upsized to about 980 million shares, fully diluted value around $1.5 trillion. Covers prospectus revenue and the $26 billion placement.
About $1.08 trillion market cap, around $1.5 trillion fully diluted
Useful on why those two valuation headlines differ.
Priced above the marketed range
Context on the last private round, reported holder stakes, and the concurrent placement.
Priced at $83, valuing the company at $1.5 trillion in the biggest debut
A concise wire account of the pricing and share split between the company and selling stockholders.
Live updates on the Nasdaq debut
Day-of trading coverage, plus a recap of prospectus revenue and the $104 billion nine-month net loss.
Thousands of employees could become millionaires
A valuation scenario, not a confirmed wealth transfer. Read the piece before repeating the headcount figures.